The Association between Estrogen Levels and Prostate Volume in Obese and NonObese Benign Prostatic Hyperplasia (BPH) Patients

Authors

  • Afsheen Khan
  • Naheed Khan
  • Syeda Bushra Ahmed
  • Asma Aijaz
  • Iffat Raza
  • Shaheen Haider

DOI:

https://doi.org/10.51985/JBUMDC2023279

Keywords:

Prostate, Estrogen, Body mass index, Obesity

Abstract

Objective: To investigate the association between prostate volume and estrogen levels in obese and non-obese individuals suffering from Benign Prostatic Hyperplasia (BPH).

 

Study Design and Setting: Cross-sectional, analytical study

 

Methodology: The International Prostatic Symptom Score (IPSS) was used in the study to recognize sixty participants with BPH. The study examined patients' height, weight, waist circumference (WC), and body mass index (BMI). An IPSS score of less than 7 was seen as healthy. Using standardized BMI (25) and waist circumference (90cm), patients were split into two groups, with obese patients being placed in group A and non-obese patients being placed in group B. Using trans-rectal ultrasonography(TRUS), prostate gland's dimensions were measured, and blood samples were taken to determine serum estrogen levels.

 

Results: In comparison to the non-obesity group, which had a mean prostate volume (PV) of 31.21±6.771 ml, the obese group's PV was 36.13±3.673ml. It was statistically significant that there was a difference between the two groups (p=0.001). In the non-obese group, average level of estrogen was 309.72±73.62pmol/l, compared to 328.21±115.05pmol/l in the obese group (p=0.462). Correlation study (r=0.279,p=0.031) revealed a significantly ideal relationship between participants' blood estrogen levels and PV. Among patients who were obese, there was a significant positive correlation among blood estrogen levels and prostate size(r=0.638, p=0.0001).

 

Conclusion: When compared to the non-obese group, obesity significantly raises prostate volume in study participants, leading to benign prostatic hypertrophy. In addition, prostate volume and blood estrogen levels in obese males showed a significant positive association.

References

Tzenios N, Tazanios ME, Chahine M. The impact of body

mass index on prostate cancer: An updated systematic review

and meta-analysis. Medicine. 2022;11:101(45). Doi:

https://doi.org/10.1097% 2FMD.0000000000030191

Khan A, Shaikh SU, Ali RA, Ahmed SB. Age and Prostatic

Volume: The Prognosis for Benign Prostatic Hyperplasia. Pak

J Med Dent. 2023;17:23-8. DOI: https://doi.org/10.

/PJMD12-2/005

Hata J, Harigane Y, Matsuoka K, Akaihata H, Yaginuma K,

Meguro S, Hoshi S, Sato Y, Ogawa S, Uemura M, Kojima Y.

Mechanism of Androgen-Independent Stromal Proliferation

in Benign Prostatic Hyperplasia. Int J Mol Sci. 2023;

(14):11634.

Mubenga LE, Hermans MP, Chimanuka D, Muhindo L,

Bwenge E, Tombal B. Prostate volume and its relationship

with anthropometric variables among different ethnic groups

of South-Kivu, DR Congo. Afr J Urol. 2020;26(1):1-7. DOI:

doi/org/10.1186/s12301-020-00040-x

Raza I, Hassan N, Gul P, Jafri A, Zehra N, Younas N.

Determination of Prostate Gland Volume by Ultrasonography

and Its Correlation with Anthropometric Measurements in a

Subset of Karachi Population. J Adv Med. 2016:1-12. DOI:

9734/ BJMMR/2016/20530

Harvey C, Pilcher J, Richenberg J, Patel U, Frauscher F.

Applications of transrectal ultrasound in prostate cancer. Brit

J Radiol. 2012;85(special_issue_1):S3-S17. doi.org/

1259/bjr/56357549

Mitterberger M, Horninger W, Aigner F, Pinggera GM, Steppan

I, Rehder P, et al. Ultrasound of the prostate. Radiol Imaging

Cancer. 2010;10(1):40. doi.org /10.1102%2F1470-

2010.0004

Chua ME, Lapitan MC, Morales ML, Roque A, Domingo JK.

annual national digital rectal exam day: impact on

prostate health awareness and disease detection. Prostate Int.

;2(1):31. DOI: http:// dx.doi.org/10.12954/PI.13039

Lee G, Shin J, Choi H, Jo A, Pan S, Bae D, et al. Cynanchum

wilfordii ameliorates testosterone-induced benign prostatic

hyperplasia by regulating 5á-reductase and androgen receptor

activities in a rat model. Nutrients. 2017;9(10):1070.

doi.org/10.3390/nu9101070

Lee C-L, Kuo H-C. Pathophysiology of benign prostate

enlargement and lower urinary tract symptoms: Current

concepts. Tzu-Chi Med J. 2017;29(2):79. doi.org/10.

%2Ftcmj.tcmj_20_17

Liao L, Chuang YC, Liu SP, Lee KS, Yoo TK, Chu R, et al.

Effect of lower urinary tract symptoms on the quality of life

and sexual function of males in China, Taiwan, and South

Korea: Subgroup analysis of a cross-sectional, populationbased study. LUTS. 2019;11(2): O78-O84. doi.org/

1111/luts.12220

Salman M, Khan AH, Sulaiman SAS, Hughes J, Khan JH,

Hussain K. The Modified Urdu version of International

Prostate Symptom Score: A psychometric validation study.

Turk J Urol. 2018;44(4):335. doi.org/ 10.5152% 2Ftud.2018.

Raza I, Mukhtar S, Kamran M. BENIGN PROSTATIC

HYPERPLASIA. TPMJ. 2017;24(03):445-52. DOI:

https://doi.org/10.29309/TPMJ/2017.24.03.1557

Ochiai A, Fritsche HA, Babaian RJ. Influence of

anthropometric measurements, age, and prostate volume on

prostate-specific antigen levels in men with a low risk of

prostate cancer. Urology.2005;66(4):819-23.

doi.org/10.1016/j.urology.2005.04.040

Zaza MM, Salem TA, Hassanin IS, Soliman MH. Effect of

body mass index on prostate volume and prostate-specific

antigen in men over 50: A cross-sectional study. Urol J. 2023;

:03915603231163349. DOI: https:// doi.org /10.1177/

Lee RK, Chung D, Chughtai B, Te AE, Kaplan SA. Central

obesity as measured by waist circumference is predictive of

severity of lower urinary tract symptoms. BJUI. 2012;110(4):

-5. doi.org/10.1111/j.1464-410X. 2011.10819.x

Wu A, Shi Z, Martin S, Vincent A, Heilbronn L, Wittert G.

Age-related changes in estradiol and longitudinal associations

with fat mass in men. PloS one. 2018;13(8). doi.org/

1371/journal.pone.0201912

Asiedu B, Anang Y, Nyarko A, Doku DA, Amoah BY, Santa

S, et al. The role of sex steroid hormones in benign prostatic

hyperplasia. Aging Male. 2017;20(1):17-22.

doi.org/10.1080/13685538.2016.1272101

Munshi F, Marthi S, Hyams E. Obesity and prostate cancer.

InThe Link Between Obesity and Cancer. 2023. Academic

Press, Elsevier:115-28. DOI:https://doi. org/10.1016/B978-

-323-90965-5.00013-1

Zeng Q-S, Xu C-L, Liu Z-Y, Wang H-Q, Yang B, Xu W-D,

et al. Relationship between serum sex hormones levels and

degree of benign prostate hyperplasia in Chinese aging men.

Asian J Androl. 2012;14(5):773. doi.org/10.1038%

Faja.2012.32

Li J, Sun H, Wang Y, Liu J, Wang G. Apolipoprotein C3 is

negatively associated with estrogen and mediates the protective

effect of estrogen on hypertriglyceridemia in obese adults.

Lipids Health Dis. 2023;22(1):1-9. doi.org10.1186/s12944-

-01797-0

Dhindsa S, Miller MG, McWhirter CL, Mager DE, Ghanim

H, Chaudhuri A, et al. Testosterone concentrations in diabetic

and nondiabetic obese men. Diabetes care. 2010;33(6):1186-

doi.org/ 10.2337 /dc09-1649

Ali A, Du Feu A, Oliveira P, Choudhury A, Bristow RG, Baena

E. Prostate zones and cancer: lost in transition?. Nat Rev

Urol. 2022;19(2):101-15. Doi.org/ s41585-021-00524-7

Ogunmoroti O, Osibogun O, Zhao D, Mehta RC, Ouyang P,

Lutsey PL, Robinson-Cohen C, Michos ED. Associations

between endogenous sex hormones and FGF-23 among women

and men in the Multi-Ethnic Study of Atherosclerosis. PloS

one. 2022. 25;17(5) :e0268759. Doi: https://doi.org/10.1371

/journal. pone.0268759

Orwoll E, Lambert LC, Marshall LM, Phipps K, Blank J,

Barrett-Connor E, et al. Testosterone and estradiol among

older men. J Clin Endocrinol Metabol. 2006;91(4):1336-44.

doi.org/10.1210/jc.2005-1830

Downloads

Published

2024-04-25

How to Cite

Khan, A. ., Khan, N. ., Ahmed, S. B. ., Aijaz, A. ., Raza, I. ., & Haider, S. . (2024). The Association between Estrogen Levels and Prostate Volume in Obese and NonObese Benign Prostatic Hyperplasia (BPH) Patients. Journal of Bahria University Medical and Dental College, 14(02), 144–149. https://doi.org/10.51985/JBUMDC2023279

Issue

Section

Original Articles

Most read articles by the same author(s)